Report Interpretation
Covering the latest research from top Wall Street investment banks
Report InterpretationHilo Research

Report Interpretation

Jinjiang’s 2Q26 results were broadly in line, with core profit modestly ahead of forecast, but domestic RevPAR weakened and unit growth lagged peers. Goldman Sachs cut FY26-28E EBITDA estimates by 5-6% and reduced its target price to Rmb24.5.

InstitutionGoldman Sachs
Date20260904
CompanyShanghai Jinjiang Int'l Hotels
Ticker600754.SS
IndustryHotels
RatingSell

Summary

Goldman Sachs maintains Sell on Jinjiang as weak RevPAR and slower expansion outweigh higher CRS contribution.

Jinjiang’s 2Q26 results were broadly in line, with core profit modestly ahead of forecast, but domestic RevPAR weakened and unit growth lagged peers. Goldman Sachs cut FY26-28E EBITDA estimates by 5-6% and reduced its target price to Rmb24.5.

Sell; 12-month target price Rmb24.50; price Rmb19.08; stated upside 28.4%.
Shanghai JinjiangHotels2Q26 resultsRevPARCRS bookingsHotel expansionSell ratingChina leisure
  • 1H26 headline net profit rose to Rmb545mn from Rmb371mn in 1H25; core net profit reached Rmb593mn.
  • Domestic RevPAR fell 2% year-on-year in 2Q26, versus 4% growth in 1Q26.
  • CRS booking contribution lifted the take rate to 9.0% in 1H26 from 8.4% in 1H25.
  • FY26-28E adjusted EBITDA estimates were reduced by 5-6%; the 12-month target price fell from Rmb25.0 to Rmb24.5.
  • The report views Jinjiang’s 7x FY27E EV/EBITDA and 16x P/E as not especially compelling against HWorld and Atour.

Report Interpretation

Overview

This earnings review assesses Shanghai Jinjiang Int'l Hotels’ 2Q26 and 1H26 performance. Goldman Sachs says results were broadly in line and core profit was slightly ahead, but weakening domestic RevPAR, slower hotel additions and unexceptional relative valuation support its maintained Sell rating.

Core views

Jinjiang reported 1H26 headline net profit of Rmb545mn, up from Rmb371mn in 1H25. Excluding one-off items, core net profit was Rmb593mn, slightly ahead of Goldman Sachs’ expectations and equal to 55% of its full-year forecast. The report attributes this relative strength to finance-cost savings from overseas debt repayment and lower tax expense. Adjusted EBITDA was broadly in line at Rmb903mn in 2Q26, down 2% year-on-year after lease-amortization adjustment; the EBITDA margin fell 1.2 percentage points to 24.5% as SG&A expense rose 11%. The main operational concern is weaker domestic demand. Domestic revenue growth slowed from 9% year-on-year in 1Q26 to 5% in 2Q26 as domestic RevPAR fell 2%, against 4% growth in 1Q26. Goldman Sachs links the slowdown to weaker travel demand amid higher airfares and unfavorable weather. Jinjiang’s RevPAR performance lagged hotel peers: HWorld grew 1.3%, Atour 0.7%, and BTG declined 1.0%. Overseas hotel revenue was broadly flat in euro terms but declined 2% in renminbi terms as the renminbi appreciated. Group revenue nevertheless increased 3% year-on-year in 2Q26 and 4% in 1H26, above management’s full-year guidance of 1-2% growth. Higher CRS booking contribution partly cushioned the slower RevPAR trend. The take rate rose to 9.0% in 1H26 from 8.4% a year earlier. Direct channels accounted for 74% of room nights sold in 2Q26, including 39.3% from CRS. Management expects CRS penetration to keep increasing through membership-benefit enhancements, AI adoption and cross-industry partnerships. The report also notes that upgraded limited-service hotels outperformed: RevPAR for L/O hotels rose 5% in July and 9% in August, while management indicated that completed franchise-hotel upgrades can lift RevPAR by about 20%. Network growth remained subdued relative to peers. Gross openings were 313 in 2Q26, compared with 306 in 1Q26, for 619 in 1H26 and in line with Jinjiang’s 1,200 full-year target. However, this target is much lower than HWorld’s 2,200-2,300 and BTG’s 1,600-1,700 planned openings. Closures fell to 169 from 205 in 1Q26, leaving hotels in operation up 1% quarter-on-quarter and 4% year-on-year to 14,404 at end-2Q26, including about 13,200 in China and 1,100 overseas, mainly in Europe. Midscale hotels grew 8% year-on-year and represented 64% of the portfolio. The 4,013-hotel pipeline was broadly stable, while roughly 650-700 new signings in 1H26 were behind the 1,800 full-year target as franchisees became more cautious and shifted toward mid-upscale formats. Goldman Sachs lowered FY26-28E adjusted EBITDA estimates by 5-6% to reflect the latest RevPAR and expansion trends, and cut its 12-month target price to Rmb24.5 from Rmb25.0. It expects slower unit growth and RevPAR pressure to result in muted revenue and EBITDA growth over coming quarters. Jinjiang’s share price had fallen 7% over the preceding three months, versus gains of 5% for HWorld and 2% for Atour. The report considers Jinjiang’s valuation of 7x FY27E EV/EBITDA and 16x P/E insufficiently compelling versus HWorld at 8x and 14x, respectively, and Atour at 7x and 14x. Goldman Sachs therefore maintains Sell as a relative call and prefers HWorld and Atour within its China hotel coverage.

Analysis framework

Goldman Sachs compares reported profit, revenue, margins, RevPAR and hotel-network metrics with its forecasts and peer operating trends. It then incorporates updated RevPAR and expansion assumptions into FY26-28E EBITDA estimates and applies a sum-of-the-parts valuation to set the 12-month target price.

Methodology notes

  • Valuation methodsSOTP (Sum-of-the-Parts) Valuation

    Sum-of-the-parts valuation using an EV/EBITDA multiple for core hotel operations.

    Goldman Sachs values Jinjiang’s core hotel-operations business at 9x FY26E EV/EBITDA, below its mid-cycle valuation, to derive the Rmb24.5 target price.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • Shanghai Jinjiang Int'l Hotels (600754.SS)
    Primary covered company; weaker RevPAR and slower network growth underpin the maintained Sell rating.
    Strengths
    Core profit was slightly ahead of forecast; CRS take rate increased to 9.0%; upgraded hotels showed stronger RevPAR.
    Weaknesses
    Domestic RevPAR declined 2% in 2Q26, and 1H26 openings and signings lagged the pace of comparable operators.
    Comparison
    The report cites FY27E valuation of 7x EV/EBITDA and 16x P/E versus HWorld at 8x/14x and Atour at 7x/14x.
    Risks
    Better macro conditions, a faster European Louvre turnaround, or faster debt repayment could improve the outlook.
  • HWorld
    Preferred peer within Goldman Sachs’ China hotel coverage universe.
    Strengths
    RevPAR rose 1.3% year-on-year and its planned annual openings of 2,200-2,300 exceed Jinjiang’s 1,200 target.
    Comparison
    Jinjiang underperformed HWorld in recent share-price and operating comparisons.
  • Atour
    Preferred peer within Goldman Sachs’ China hotel coverage universe.
    Strengths
    RevPAR rose 0.7% year-on-year; the report cites a 7x FY27E EV/EBITDA and 14x P/E valuation.
    Comparison
    Jinjiang’s 16x FY27E P/E is above Atour’s 14x despite weaker operating momentum.

Key data

  • 1H26 headline net profitRmb545mnUp from Rmb371mn in 1H25.
  • 1H26 core net profitRmb593mnSlightly ahead of forecast and 55% of Goldman Sachs’ full-year forecast.
  • 2Q26 adjusted EBITDARmb903mnDown 2% year-on-year, with margin down 1.2 percentage points to 24.5%.
  • 2Q26 domestic RevPAR-2% YoYCompared with 4% year-on-year growth in 1Q26.
  • 1H26 CRS take rate9.0%Up from 8.4% in 1H25.
  • Hotels in operation at end-2Q2614,404Up 1% quarter-on-quarter and 4% year-on-year.
  • FY26-28E adjusted EBITDA revision-6% to -5%Cut following RevPAR weakness and slower expansion progress.
  • FY27E valuation7x EV/EBITDA and 16x P/EThe report judges this not particularly compelling versus HWorld and Atour.

Impact & implications

The report argues that higher CRS monetization and franchise upgrades provide partial offsets, but they do not overcome near-term pressure from weak domestic RevPAR and slower signings. On Goldman Sachs’ view, these operating trends and relative valuation justify maintaining Sell and favoring HWorld and Atour instead within the coverage universe.

Risks

  • A better-than-expected macro environment could drive faster-than-expected RevPAR growth.
  • Jinjiang’s Louvre business in Europe could turn around faster than expected.
  • Debt swaps or other capital allocation could enable faster-than-expected debt repayment.

What to watch

  • Domestic RevPAR progression, particularly management’s goal of stable full-year RevPAR after July’s 3% decline and flat August trend.
  • New hotel openings and signings against the 1,200 opening and 1,800 signing full-year targets.
  • Further CRS mix gains from membership upgrades, AI adoption and cross-industry partnerships.
  • The pace and RevPAR benefit of franchise-hotel upgrades and renovation.
  • The recovery of the Louvre business in Europe and progress on debt repayment.
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins